SearchDictionaryMobileLogin

Susan E Hankinson Selected Research

Breast Neoplasms (Breast Cancer)

08/2008Circulating 2-Hydroxy- and 16{alpha}-Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women.
03/2008Prolactin and breast cancer etiology: an epidemiologic perspective.
01/2008Haplotypes of the estrogen receptor beta gene and breast cancer risk.
01/2008IGF-1, IGFBP-1, and IGFBP-3 Polymorphisms Predict Circulating IGF Levels but Not Breast Cancer Risk: Findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
01/2008Circulating levels of sex steroids and prolactin in premenopausal women and risk of breast cancer.
12/2007Nutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer among Premenopausal Women.
08/2007Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
08/2007Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.
04/2007A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
04/2007Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
04/2007Plasma adiponectin concentrations and risk of incident breast cancer.
03/2007Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
01/2007Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
01/2007A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study.
11/2006Prolactin and breast cancer risk.
11/2006Dietary fat and risk of postmenopausal breast cancer in a 20-year follow-up.
10/2006Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
07/2006Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
07/2006Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk.
06/2006Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
05/2006Unopposed estrogen therapy and the risk of invasive breast cancer.
05/2006The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
04/2006Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?
04/2006Tubal sterilization in relation to breast cancer risk.
02/2006Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
02/2006GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.
02/2006Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).
01/2006Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
01/2006A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
10/2005Serum lipids, lipid-lowering drugs, and the risk of breast cancer.
10/2005Associations between polymorphisms in the vitamin D receptor and breast cancer risk.
08/2005Folate intake and risk of breast cancer characterized by hormone receptor status.
08/2005Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
07/2005Urinary melatonin levels and breast cancer risk.
07/2005The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk.
04/2005Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
03/2005Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
01/2005Plasma carotenoids, retinol, and tocopherols and risk of breast cancer.
01/2005Endogenous hormones and risk of breast cancer in postmenopausal women.
12/2004Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
10/2004Cataract extraction and risk of breast cancer.
09/2004Plasma prolactin concentrations and risk of postmenopausal breast cancer.
06/2004Caregiving stress, endogenous sex steroid hormone levels, and breast cancer incidence.
06/2004Plasma adrenal androgens and risk of breast cancer in premenopausal women.
06/2004Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer.
04/2004Dietary carbohydrates, fiber, and breast cancer risk.
02/2004Risk factors for breast cancer according to estrogen and progesterone receptor status.
02/2004Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study.
01/2004Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones.
01/2004The progesterone receptor Val660-->Leu polymorphism and breast cancer risk.
12/2003A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk.
11/2003A prospective study of plasma total cysteine and risk of breast cancer.
10/2003Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk.
09/2003A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
03/2003Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.
01/2003Insulin-like growth factor and breast cancer risk: evidence from observational studies.
12/2002Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study.
11/2002Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer.
11/2002Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass.
10/2002No association between a stop codon polymorphism in RAD52 and breast cancer risk.
09/2002Intake of dairy products, calcium, and vitamin d and risk of breast cancer.
07/2002A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.
05/2002Association of CYP1B1 polymorphisms and breast cancer risk.
02/2002The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
02/2002No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.

Articles by Research Topic

Disease

65Breast Neoplasms (Breast Cancer)
08/2008 - 02/2002
11Ovarian Neoplasms (Ovarian Cancer)
09/2008 - 07/2002
9Endometrial Neoplasms (Endometrial Cancer)
04/2008 - 09/2002
4Colorectal Neoplasms (Colorectal Cancer)
12/2006 - 09/2004
4Adenoma (Adenomas)
04/2006 - 11/2002
3Macular Degeneration (Age-Related Maculopathy)
06/2008 - 06/2004
3Prostatic Neoplasms (Prostate Cancer)
01/2008 - 01/2006
3Coronary Disease (Coronary Heart Disease)
04/2007 - 12/2004
3Cataract (Cataracts)
04/2005 - 03/2002
2Myocardial Infarction
10/2008 - 07/2008
2Open-Angle Glaucoma (Glaucoma, Open Angle)
05/2008 - 05/2004
2Carcinoma (Carcinomatosis)
10/2004 - 02/2003
1Infertility (Sterility)
10/2007
1Diabetes Mellitus
07/2005
1Premenstrual Syndrome (Premenstrual Tension)
06/2005
1Inflammation
04/2004
1Chronic Disease (Chronic Diseases)
03/2002

Drug/Important Bio-Agent (IBA)

11HormonesIBA
01/2008 - 07/2002
8ProlactinIBA
03/2008 - 02/2003
7Estrogens (Estrogen)FDA Link
08/2007 - 02/2004
6Progesterone Receptors (Progesterone Receptor)IBA
02/2006 - 09/2002
5Insulin (Novolin)FDA Link
01/2007 - 07/2002
5Dietary Fats (Ghee)IBA
11/2006 - 07/2002
5Carotenoids (Carotene)IBA
11/2006 - 03/2002
4Insulin-Like Growth Factor I (IGF-1)IBA
01/2008 - 11/2002
4C-PeptideIBA
01/2007 - 04/2005
4Vitamin DFDA LinkGeneric
06/2005 - 09/2002
3Carrier Proteins (Binding Protein)IBA
10/2008 - 03/2005
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2007 - 12/2002
3Somatomedins (Somatomedin)IBA
08/2007 - 10/2003
3DNA (Deoxyribonucleic Acid)IBA
11/2006 - 02/2004
3Androgen Receptors (Androgen Receptor)IBA
03/2006 - 02/2002
2Dehydroepiandrosterone (DHEA)IBA
07/2008 - 05/2006
2zeaxanthinIBA
06/2008 - 03/2002
2LuteinIBA
06/2008 - 03/2002
2Caffeine (No Doz)FDA LinkGeneric
05/2008 - 03/2008
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2008 - 08/2002
2Estrogen Receptor betaIBA
01/2008 - 08/2004
2CarbonIBA
12/2007 - 12/2006
2ProgesteroneFDA LinkGeneric
08/2007 - 12/2004
2Testosterone (Sustanon)FDA LinkGeneric
08/2007 - 07/2006
2Trans Fatty AcidsIBA
04/2007 - 04/2004
225-hydroxyvitamin DIBA
04/2007 - 08/2005
21,25-dihydroxyvitamin DIBA
04/2007 - 08/2005
2CholesterolIBA
04/2006 - 08/2005
2LipidsIBA
10/2005 - 12/2004
2Aromatase (CYP19)IBA
08/2005 - 02/2002
2CalciumIBA
06/2005 - 09/2002
2Vitamin B 6IBA
05/2005 - 03/2003
2Vitamin A (Retinol)FDA Link
01/2005 - 10/2003
2PPAR gammaIBA
12/2004 - 11/2002
2HomocysteineIBA
12/2004 - 03/2003
2VitaminsIBA
06/2004 - 03/2002
2Codon (Codons)IBA
11/2002 - 10/2002
1TalcFDA Link
09/2008
1Estrone (Folliculin)FDA Link
08/2008
1Acetaminophen (Paracetamol)FDA LinkGeneric
04/2008
1Insulin-Like Growth Factor Binding Protein 3IBA
01/2008
1Insulin-Like Growth Factor Binding Protein 1IBA
01/2008
1SteroidsIBA
01/2008
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
11/2007
1MicronutrientsIBA
09/2007
1ZincIBA
09/2007
1AdiponectinIBA
04/2007
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2007
13' Untranslated Regions (3' UTR)IBA
01/2007
1Growth Hormone (Somatotropin)IBA
06/2006
1Dehydroepiandrosterone SulfateIBA
05/2006
1Glycosylated Hemoglobin A (Glycosylated Hemoglobin)IBA
04/2006
1aurora kinase (aurora A kinase)IBA
02/2006
1TamoxifenFDA LinkGeneric
01/2006
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2006
1Calcitriol Receptors (Calcitriol Receptor)IBA
10/2005
1Lipoprotein(a)IBA
08/2005
1MelatoninIBA
07/2005
1erbB-2 Receptor (Receptor, erbB 2)IBA
07/2005
1TocopherolsFDA Link
01/2005
1Biological Markers (Surrogate Marker)IBA
12/2004
1Epoxide HydrolasesIBA
07/2004
1LactoseFDA LinkGeneric
06/2004
1Superoxide DismutaseIBA
06/2004
1AndrogensIBA
06/2004
1AntioxidantsIBA
06/2004
1Dietary Carbohydrates (Carbohydrate, Dietary)IBA
04/2004
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
04/2004
1Cysteine (L-Cysteine)FDA Link
11/2003
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
03/2003
1Polychlorinated Biphenyls (PCBs)IBA
12/2002
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2002
1cytochrome P-450 CYP1B1 (CYP1B1)IBA
05/2002

Therapy/Procedure

1Contraception (Birth Control)
10/2007
1Tubal Sterilization (Tubal Ligation)
04/2006
1Cataract Extraction
10/2004
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
10/2004